Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer

We aimed to evaluate the patient-reported outcomes (PROs) in a prospective phase III clinical trial, comparing neoadjuvant endocrine therapy (NET) with conventional neoadjuvant chemotherapy (NCT) in patients with hormone status positive, lymph node-positive premenopausal breast cancer (NCT01622361)....

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Sungchan Gwark, Sei Hyun Ahn, Woo Chul Noh, Eun Sook Lee, Yongsik Jung, Lee Su Kim, Wonshik Han, Seok Jin Nam, Gyungyub Gong, Seon-Ok Kim, Hee Jeong Kim
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2021-07-01
סדרה:	Frontiers in Oncology
נושאים:	quality of life neoadjuvant chemotherapy neoadjuvant endocrine therapy patient-reported outcomes Neoadjuvant stusdy of chemotherapy versus Endocrine therapy in premenopausal patient with hormone responsive HER2-negative
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fonc.2021.608207/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!